FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883257130> ?p ?o ?g. }

• W2883257130 endingPage "1192.e5" @default.
• W2883257130 startingPage "1180" @default.
• W2883257130 abstract "Purpose The evidence has suggested that resveratrol has anti-inflammatory effect; however, the results are inconsistent and inconclusive. The aim of this study was to assess the effect of resveratrol supplementation on the levels of inflammatory markers through a systematic review and meta-analysis of available randomized controlled trials (RCTs). Methods A search strategy was completed using Medline, ISI Web of Science, Directory of Open Access Journal, SID, ProQuest, Cochrane Library, Scopus, and EMBASE up to May 2017, to identify placebo-controlled RCTs that assessed resveratrol effects on circulating (serum and plasma) inflammatory markers (interleukin [IL]-6, tumor necrosis factor–α [TNF-α], and high-sensitivity C-reactive protein [hs-CRP]) among adult participants aged 17 years and older in 17 RCTs with a total of 736 subjects. The evaluation of study quality was performed using the Jadad scale. Weighted mean difference (WMD) was calculated for evaluating the changes in the inflammatory markers using fixed-effects or random-effects models. We performed subgroup and sensitivity analyses to evaluate the heterogeneity of the studies. Findings Seventeen RCTs, including 736 subjects, fulfilled the eligibility criteria and were selected for analyses. The results of meta-analysis found significant reductions in the level of TNF-α (WMD, –0.44; 95% CI, –0.71 to –0.164; P = 0.002; Q statistic = 21.60; I2 = 49.1%; P = 0.02) and hs-CRP (WMD, –0.27; 95% CI, –0.5 to –0.02; P = 0.033; Q statistic = 26.95; I2 = 51.8%; P = 0.013) after supplementation with resveratrol. Resveratrol supplementation had no significant effect on the level of IL-6 (WMD, –0.16; 95% CI, –0.53 to 0.20; P = 0.38; Q statistic = 36.0; I2 = 72.3%; P = 0.001). Statistically significant heterogeneity was observed for the type of sample in IL-6 and study duration in inflammatory markers IL-6, TNF-α, and hs-CRP. Implications Available evidence from RCTs suggests that resveratrol supplementation significantly reduced TNF-α and hs-CRP levels. Significant improvement in inflammatory markers support resveratrol as an adjunct to pharmacologic management of metabolic diseases." @default.
• W2883257130 created "2018-08-03" @default.
• W2883257130 creator A5012391705 @default.
• W2883257130 creator A5043588001 @default.
• W2883257130 creator A5080177896 @default.
• W2883257130 date "2018-07-01" @default.
• W2883257130 modified "2023-09-26" @default.
• W2883257130 title "Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials" @default.
• W2883257130 cites W1490066329 @default.
• W2883257130 cites W1569565225 @default.
• W2883257130 cites W1812416290 @default.
• W2883257130 cites W1866779716 @default.
• W2883257130 cites W1911916202 @default.
• W2883257130 cites W1964986597 @default.
• W2883257130 cites W1969915228 @default.
• W2883257130 cites W1974269714 @default.
• W2883257130 cites W1977384490 @default.
• W2883257130 cites W1984225039 @default.
• W2883257130 cites W1986215651 @default.
• W2883257130 cites W1990886132 @default.
• W2883257130 cites W2003504981 @default.
• W2883257130 cites W2004199712 @default.
• W2883257130 cites W2008658418 @default.
• W2883257130 cites W2013129557 @default.
• W2883257130 cites W2015038189 @default.
• W2883257130 cites W2021631452 @default.
• W2883257130 cites W2029258625 @default.
• W2883257130 cites W2031213396 @default.
• W2883257130 cites W2039701298 @default.
• W2883257130 cites W2042685638 @default.
• W2883257130 cites W2063920680 @default.
• W2883257130 cites W2071706440 @default.
• W2883257130 cites W2074601722 @default.
• W2883257130 cites W2076048864 @default.
• W2883257130 cites W2078046698 @default.
• W2883257130 cites W2088366586 @default.
• W2883257130 cites W2097285161 @default.
• W2883257130 cites W2098448061 @default.
• W2883257130 cites W2102470188 @default.
• W2883257130 cites W2114968425 @default.
• W2883257130 cites W2117499294 @default.
• W2883257130 cites W2129316761 @default.
• W2883257130 cites W2142272708 @default.
• W2883257130 cites W2144770293 @default.
• W2883257130 cites W2156849286 @default.
• W2883257130 cites W2159087408 @default.
• W2883257130 cites W2165722123 @default.
• W2883257130 cites W2194294353 @default.
• W2883257130 cites W2508784513 @default.
• W2883257130 cites W2517966366 @default.
• W2883257130 cites W2748698351 @default.
• W2883257130 cites W2795678388 @default.
• W2883257130 cites W4294215472 @default.
• W2883257130 doi "https://doi.org/10.1016/j.clinthera.2018.05.015" @default.
• W2883257130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30017172" @default.
• W2883257130 hasPublicationYear "2018" @default.
• W2883257130 type Work @default.
• W2883257130 sameAs 2883257130 @default.
• W2883257130 citedByCount "52" @default.
• W2883257130 countsByYear W28832571302018 @default.
• W2883257130 countsByYear W28832571302019 @default.
• W2883257130 countsByYear W28832571302020 @default.
• W2883257130 countsByYear W28832571302021 @default.
• W2883257130 countsByYear W28832571302022 @default.
• W2883257130 countsByYear W28832571302023 @default.
• W2883257130 crossrefType "journal-article" @default.
• W2883257130 hasAuthorship W2883257130A5012391705 @default.
• W2883257130 hasAuthorship W2883257130A5043588001 @default.
• W2883257130 hasAuthorship W2883257130A5080177896 @default.
• W2883257130 hasConcept C126322002 @default.
• W2883257130 hasConcept C136524200 @default.
• W2883257130 hasConcept C142724271 @default.
• W2883257130 hasConcept C168563851 @default.
• W2883257130 hasConcept C17744445 @default.
• W2883257130 hasConcept C187960798 @default.
• W2883257130 hasConcept C199539241 @default.
• W2883257130 hasConcept C204787440 @default.
• W2883257130 hasConcept C27081682 @default.
• W2883257130 hasConcept C2776478404 @default.
• W2883257130 hasConcept C2776816829 @default.
• W2883257130 hasConcept C2779473830 @default.
• W2883257130 hasConcept C71924100 @default.
• W2883257130 hasConcept C90924648 @default.
• W2883257130 hasConcept C95190672 @default.
• W2883257130 hasConcept C98274493 @default.
• W2883257130 hasConceptScore W2883257130C126322002 @default.
• W2883257130 hasConceptScore W2883257130C136524200 @default.
• W2883257130 hasConceptScore W2883257130C142724271 @default.
• W2883257130 hasConceptScore W2883257130C168563851 @default.
• W2883257130 hasConceptScore W2883257130C17744445 @default.
• W2883257130 hasConceptScore W2883257130C187960798 @default.
• W2883257130 hasConceptScore W2883257130C199539241 @default.
• W2883257130 hasConceptScore W2883257130C204787440 @default.
• W2883257130 hasConceptScore W2883257130C27081682 @default.
• W2883257130 hasConceptScore W2883257130C2776478404 @default.
• W2883257130 hasConceptScore W2883257130C2776816829 @default.
• W2883257130 hasConceptScore W2883257130C2779473830 @default.
• W2883257130 hasConceptScore W2883257130C71924100 @default.

• next